Published in Respir Res on September 28, 2007
cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther (2012) 1.24
Activation of endogenous GABAA channels on airway smooth muscle potentiates isoproterenol-mediated relaxation. Am J Physiol Lung Cell Mol Physiol (2008) 1.13
The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease. Curr Opin Pharmacol (2014) 1.13
PLAUR polymorphisms and lung function in UK smokers. BMC Med Genet (2009) 0.91
Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells. BMC Mol Biol (2009) 0.85
Integration of metabolomic and transcriptomic networks in pregnant women reveals biological pathways and predictive signatures associated with preeclampsia. Metabolomics (2016) 0.75
Requirement for IL-13 independently of IL-4 in experimental asthma. Science (1998) 10.76
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest (2006) 8.43
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med (2000) 4.11
Cytokines in symptomatic asthma airways. J Allergy Clin Immunol (1992) 3.01
Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med (1992) 2.52
IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol (1995) 2.18
Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med (2004) 1.88
Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res (2003) 1.82
Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol (1990) 1.80
Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Am J Physiol Renal Physiol (2005) 1.70
CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J (2003) 1.63
Regulation of eotaxin gene expression by TNF-alpha and IL-4 through mRNA stabilization: involvement of the RNA-binding protein HuR. J Immunol (2003) 1.57
Rhinovirus-induced interferon-gamma and airway responsiveness in asthma. Am J Respir Crit Care Med (2003) 1.57
Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax (1993) 1.53
Members of the Gq alpha subunit gene family activate phospholipase C beta isozymes. J Biol Chem (1992) 1.48
Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol (2004) 1.43
Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway. J Biol Chem (1996) 1.42
IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol (2003) 1.35
Second messengers, ion channels and pharmacology of airway smooth muscle. Eur Respir J (2000) 1.30
Transcription factors and asthma. Eur Respir J (1998) 1.23
CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2005) 1.23
The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun Rev (2005) 1.21
TNF-alpha upregulates Gialpha and Gqalpha protein expression and function in human airway smooth muscle cells. Am J Physiol (1999) 1.18
Mechanisms underlying TNF-alpha effects on agonist-mediated calcium homeostasis in human airway smooth muscle cells. Am J Physiol (1997) 1.13
Control of histamine induced inositol phospholipid hydrolysis in cultured human tracheal smooth muscle cells. Eur J Pharmacol (1993) 1.09
Potentiation by tumour necrosis factor-alpha of calcium signals induced by bradykinin and carbachol in human tracheal smooth muscle cells. Br J Pharmacol (1995) 1.08
Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J Allergy Clin Immunol (2002) 1.02
Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol (2004) 1.01
Identification of polymorphic sites of the human bradykinin B2 receptor gene. Biochem Biophys Res Commun (1995) 0.98
Airway hyperresponsiveness: a story of mice and men and cytokines. Clin Rev Allergy Immunol (2003) 0.98
Bronchial hyperresponsiveness: insights into new signaling molecules. Curr Opin Pharmacol (2004) 0.98
The effect of beta2-adrenoceptor agonists on phospholipase C (beta1) signalling in human airway smooth muscle cells. Eur J Pharmacol (2006) 0.97
Direct effects of Th2 cytokines on airway smooth muscle. Curr Opin Pharmacol (2004) 0.96
Signalling pathway for histamine activation of non-selective cation channels in equine tracheal myocytes. J Physiol (2000) 0.93
Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. Eur J Pharmacol (2004) 0.92
Regulation of histamine H1 receptor coupling by dexamethasone in human cultured airway smooth muscle. Br J Pharmacol (1996) 0.90
Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes. Am J Respir Crit Care Med (2001) 0.90
The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region. Biochem Biophys Res Commun (1995) 0.89
Post-transcriptional regulation of bradykinin B1 and B2 receptor gene expression in human lung fibroblasts by tumor necrosis factor-alpha: modulation by dexamethasone. Mol Pharmacol (2000) 0.88
Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2001) 0.88
Interleukin-1beta induces bradykinin B2 receptor gene expression through a prostanoid cyclic AMP-dependent pathway in human bronchial smooth muscle cells. Mol Pharmacol (1998) 0.88
Mechanisms of interleukin 1beta-induced human airway smooth muscle hyporesponsiveness to histamine. Involvement of p38 MAPK NF-kappaB. Am J Respir Crit Care Med (2001) 0.87
Up-regulation of airway smooth muscle histamine H(1) receptor mRNA, protein, and function by beta(2)-adrenoceptor activation. Mol Pharmacol (2000) 0.86
Agonist-induced translocation of Gq/11alpha immunoreactivity directly from plasma membrane in MDCK cells. Am J Physiol (1999) 0.86
Improvement in bronchial hyperresponsiveness with inhaled corticosteroids in children with asthma: importance of family history of bronchial hyperresponsiveness. Am J Respir Crit Care Med (2002) 0.81
Alternative promoter use and splice variation in the human histamine H1 receptor gene. Am J Respir Cell Mol Biol (2006) 0.81
3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression. Am J Physiol Renal Physiol (2005) 0.79
Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet (2009) 6.83
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels. FASEB J (2013) 2.16
Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med (2011) 2.07
Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study. Lancet (2006) 1.84
A sequence variant on 17q21 is associated with age at onset and severity of asthma. Eur J Hum Genet (2010) 1.74
Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology (2011) 1.70
IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol (2013) 1.70
Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am J Physiol Lung Cell Mol Physiol (2002) 1.69
Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling. Mol Pharmacol (2003) 1.67
Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor. Mol Pharmacol (2003) 1.52
Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet (2012) 1.52
ORAI and store-operated calcium influx in human airway smooth muscle cells. Am J Respir Cell Mol Biol (2008) 1.50
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med (2012) 1.49
Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer. Int J Cancer (2008) 1.48
Are beta2-adrenoceptor polymorphisms important in asthma--an unravelling story. Lancet (2004) 1.43
A key role for STIM1 in store operated calcium channel activation in airway smooth muscle. Respir Res (2006) 1.43
Evaluation of differentiated human bronchial epithelial cell culture systems for asthma research. J Allergy (Cairo) (2012) 1.39
The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br J Clin Pharmacol (2004) 1.38
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut (2012) 1.30
Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology (2005) 1.25
Meta-analysis of genome-wide linkage studies of asthma and related traits. Respir Res (2008) 1.16
Glucocorticoids increase repair potential in a novel in vitro human airway epithelial wounding model. J Clin Immunol (2006) 1.13
A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One (2011) 1.13
Expression of transient receptor potential C6 and related transient receptor potential family members in human airway smooth muscle and lung tissue. Am J Respir Cell Mol Biol (2003) 1.10
Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor. Br J Pharmacol (2002) 1.08
PLAUR polymorphisms are associated with asthma, PLAUR levels, and lung function decline. J Allergy Clin Immunol (2009) 1.04
Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter. J Biol Chem (2002) 1.04
Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol (2003) 1.02
Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance. Am J Respir Crit Care Med (2007) 1.02
Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol (2004) 1.01
uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium. Thorax (2011) 1.01
Pharmacology and direct visualisation of BODIPY-TMR-CGP: a long-acting fluorescent beta2-adrenoceptor agonist. Br J Pharmacol (2003) 1.00
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. PLoS Genet (2013) 0.97
The effect of beta2-adrenoceptor agonists on phospholipase C (beta1) signalling in human airway smooth muscle cells. Eur J Pharmacol (2006) 0.97
Reverse mode Na+/Ca2+ exchange mediated by STIM1 contributes to Ca2+ influx in airway smooth muscle following agonist stimulation. Respir Res (2010) 0.96
A major functional role for phosphodiesterase 4D5 in human airway smooth muscle cells. Am J Respir Cell Mol Biol (2007) 0.96
Extracellular matrix modulates beta2-adrenergic receptor signaling in human airway smooth muscle cells. Am J Respir Cell Mol Biol (2004) 0.95
GSTCD and INTS12 regulation and expression in the human lung. PLoS One (2013) 0.94
Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report. COPD (2011) 0.93
Pharmacogenetics of asthma. Br J Clin Pharmacol (2002) 0.93
Novel cAMP signalling paradigms: therapeutic implications for airway disease. Br J Pharmacol (2012) 0.92
Recognition of the major cat allergen Fel d 1 through the cysteine-rich domain of the mannose receptor determines its allergenicity. J Biol Chem (2011) 0.92
PLAUR polymorphisms and lung function in UK smokers. BMC Med Genet (2009) 0.91
Temporal characteristics of cAMP response element-mediated gene transcription: requirement for sustained cAMP production. Mol Pharmacol (2004) 0.89
Airway myofibroblasts and their relationship with airway myocytes and fibroblasts. Proc Am Thorac Soc (2008) 0.88
Biosynthesized matrix provides a key role for survival signaling in bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol (2003) 0.87
Bradykinin activates calcium-dependent potassium channels in cultured human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2006) 0.86
Eosinophil-mediated cholinergic nerve remodeling. Am J Respir Cell Mol Biol (2006) 0.86
Personalised prescribing for asthma--is pharmacogenetics the answer? J Pharm Pharmacol (2003) 0.86
Urokinase receptor orchestrates the plasminogen system in airway epithelial cell function. Lung (2013) 0.86
Characterization of protocadherin-1 expression in primary bronchial epithelial cells: association with epithelial cell differentiation. FASEB J (2011) 0.85
Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cells. BMC Mol Biol (2009) 0.85
Nickel induces intracellular calcium mobilization and pathophysiological responses in human cultured airway epithelial cells. Chem Biol Interact (2010) 0.85
Genetic basis for personalized medicine in asthma. Expert Rev Respir Med (2012) 0.84
HTR4 gene structure and altered expression in the developing lung. Respir Res (2013) 0.83
Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies. Br J Pharmacol (2011) 0.83
Evidence of a genetic contribution to lung function decline in asthma. J Allergy Clin Immunol (2011) 0.83
Identification of the autoantigen SART-1 as a candidate gene for the development of atopy. Hum Mol Genet (2002) 0.83
A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation? Br J Clin Pharmacol (2015) 0.83
Pharmacogenetic approaches in the treatment of asthma. Curr Allergy Asthma Rep (2005) 0.82
Current progress in pharmacogenetics. Br J Clin Pharmacol (2011) 0.82
Pulmonary MRI contrast using Surface Quadrupolar Relaxation (SQUARE) of hyperpolarized (83)Kr. Magn Reson Imaging (2013) 0.82
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum Genet (2006) 0.81
Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle. Am J Respir Cell Mol Biol (2003) 0.81
A genome-wide association study to identify genetic determinants of atopy in subjects from the United Kingdom. J Allergy Clin Immunol (2010) 0.81
Alternative promoter use and splice variation in the human histamine H1 receptor gene. Am J Respir Cell Mol Biol (2006) 0.81
ADRB2 polymorphisms and beta2 agonists. Lancet (2007) 0.80
Can lineage-specific markers be identified to characterize mesenchyme-derived cell populations in the human airways? Am J Physiol Lung Cell Mol Physiol (2010) 0.80
Leukotriene B4 receptor locus gene characterisation and association studies in asthma. BMC Med Genet (2012) 0.79
Defining the contribution of SNPs identified in asthma GWAS to clinical variables in asthmatic children. BMC Med Genet (2013) 0.79
The genetics of obstructive lung disease: big is beautiful. Thorax (2010) 0.79
Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation. Thromb Haemost (2005) 0.79
The role of ALOX5AP, LTA4H and LTB4R polymorphisms in determining baseline lung function and COPD susceptibility in UK smokers. BMC Med Genet (2011) 0.79
5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists. Eur J Clin Pharmacol (2002) 0.78
Functional polymorphism and differential regulation of CYSLTR1 transcription in human airway smooth muscle and monocytes. Cell Biochem Biophys (2007) 0.77
Real time analysis of β(2)-adrenoceptor-mediated signaling kinetics in human primary airway smooth muscle cells reveals both ligand and dose dependent differences. Respir Res (2011) 0.76